Antag Therapeutics is a Biotech company. It has raised $86M in total funding. Latest round: Series A. Backed by Versant Ventures, Novo Holdings, SR One.
Antag Therapeutics is a Biotech company. Antag Therapeutics has raised $86M in total disclosed funding. That places its disclosed total in the $25M–$100M range. Its most recent disclosed round is a Series A announced in December 2024. The round record for Antag Therapeutics runs through 2024; nothing later has been disclosed. Investors on record include Versant Ventures, Novo Holdings, SR One, Dawn Biopharma, Pictet. 5 distinct backers are named across the disclosed rounds.
Totals shown for Antag Therapeutics aggregate every disclosed round on file. To see how that compares, browse the Biotech companies and the investors behind them below.
Company funding database · Investor directory · Founder database · Mega-rounds 2026